β-N-acetylglucosaminylglycopeptide β-1,4-galactosyltransferase

inquiry

Cat No.

EXWM-2584

Description

Terminal N-acetyl-β-D-glucosaminyl residues in polysaccharides, glycoproteins and glycopeptides can act as acceptor. High activity is shown towards such residues in branched-chain polysaccharides when these are linked by β-1,6-links to galactose residues; lower activity towards residues linked to galactose by β-1,3-links. A component of EC 2.4.1.22 (lactose synthase).

Form

Liquid or lyophilized powder

Enzyme Commission Number

EC 2.4.1.38

CAS_No

37237-43-7

Storage

Store it at +4 ºC for short term. For long term storage, store it at -20 ºC～-80 ºC.

Synonyms

UDP-galactose-glycoprotein galactosyltransferase; glycoprotein 4-β-galactosyl-transferase; β-N-acetyl-β1-4-galactosyltransferase; thyroid glycoprotein β-galactosyltransferase; glycoprotein β-galactosyltransferase; thyroid galactosyltransferase; uridine diphosphogalactose-glycoprotein galactosyltransferase; β-N-acetylglucosaminyl-glycopeptide β-1,4-galactosyltransferase; GalT; UDP-galactose:N-acetyl-β-D-glucosaminylglycopeptide β-1,4-galactosyltransferase; UDP-galactose:N-acetyl-β-D-glucosaminylglycopeptide 4-β-galactosyltransferase

Reaction

UDP-α-D-galactose + N-acetyl-β-D-glucosaminylglycopeptide = UDP + β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminylglycopeptide

Notes

This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.

"Galactosyltransferase" Total Products Page

Enzymes

Catalog	Product Name	EC No.	CAS No.	Source	Price
NATE-1480	α-1,3-Galactosyltransferase from Bovine, Recombinant	EC 2.4.1.87	128449-51-4	E. coli	Inquiry
NATE-1479	α-1,4-Galactosyltransferase from Neisseria meningitides, Recombinant	EC 2.4.1.228	52725-57-2	E. coli	Inquiry
NATE-0760	Native Bovine β-1,4-Galactosyl Transferase	EC 2.4.1.22	9030-11-9	Bovine milk	Inquiry
NATE-1488	β-1,3-galactosyltransferase from Campylobacter jejuni, Recombinant	EC 2.4.1.62	37217-28-0	E. coli	Inquiry

+ See More >>

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry